Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David J F Smith

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Respirology (Carlton, Vic.)|April 30, 2023
Contemporary Concise Review 2022: Interstitial lung diseaseDavid J F Smith, R Gisli Jenkins
Endocrine Connections|October 12, 2017
Prednisolone has the same cardiovascular risk profile as hydrocortisone in glucocorticoid replacementDavid J F Smith, Hemanth Prabhudev, Sirazum Choudhury, et al.
Current Opinion in Pulmonary Medicine|July 14, 2020
Oxygen for interstitial lung diseasesYet H Khor, David J F Smith, Kerri A Johannson, et al.
Respirology Case Reports|October 16, 2023
Sarcoidosis following COVID infection: A case seriesDavid J F Smith, Jamilah Meghji, Mufaddal Moonim, et al.
American Journal of Respiratory and Critical Care Medicine|February 1, 2024
Cough Severity Visual Analog Scale Assesses Cough Burden and Predicts Survival in Idiopathic Pulmonary FibrosisZhe Wu, David J F Smith, Leda Yazbeck, et al.
Expert Review of Clinical Immunology|May 15, 2026
A framework for translational research in interstitial lung disease (ILD) using bronchoalveolar lavage (bal)Connar M A Mawer, Stefan C Stanel, Emily M Ward, et al.
Respiratory Research|February 15, 2023
Epithelial senescence in idiopathic pulmonary fibrosis is propagated by small extracellular vesiclesSabha Asghar, Susan Monkley, David J F Smith, et al.
Access Microbiology|June 24, 2026
Investigating the lasting effects of SARS-CoV-2 infection and the lung microbiome: no persistent microbial alterations in recovered COVID-19 patients with persistent radiological or respiratory abnormalitiesNancy M Y Teng, Bavithra Vijayakumar, David J F Smith, et al.
The Lancet. Respiratory Medicine|May 22, 2023
Respiratory sequelae of COVID-19: pulmonary and extrapulmonary origins, and approaches to clinical care and rehabilitationSally J Singh, Molly M Baldwin, Enya Daynes, et al.
Annals of the American Thoracic Society|May 9, 2023
The Burden and Impact of Cough in Patients with Idiopathic Pulmonary Fibrosis: An Analysis of the Prospective Observational PROFILE StudyPeter Saunders, Zhe Wu, William A Fahy, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Respirology (Carlton, Vic.)|April 30, 2023
Contemporary Concise Review 2022: Interstitial lung diseaseDavid J F Smith, R Gisli Jenkins
Endocrine Connections|October 12, 2017
Prednisolone has the same cardiovascular risk profile as hydrocortisone in glucocorticoid replacementDavid J F Smith, Hemanth Prabhudev, Sirazum Choudhury, et al.
Current Opinion in Pulmonary Medicine|July 14, 2020
Oxygen for interstitial lung diseasesYet H Khor, David J F Smith, Kerri A Johannson, et al.
Respirology Case Reports|October 16, 2023
Sarcoidosis following COVID infection: A case seriesDavid J F Smith, Jamilah Meghji, Mufaddal Moonim, et al.
American Journal of Respiratory and Critical Care Medicine|February 1, 2024
Cough Severity Visual Analog Scale Assesses Cough Burden and Predicts Survival in Idiopathic Pulmonary FibrosisZhe Wu, David J F Smith, Leda Yazbeck, et al.
Expert Review of Clinical Immunology|May 15, 2026
A framework for translational research in interstitial lung disease (ILD) using bronchoalveolar lavage (bal)Connar M A Mawer, Stefan C Stanel, Emily M Ward, et al.
Respiratory Research|February 15, 2023
Epithelial senescence in idiopathic pulmonary fibrosis is propagated by small extracellular vesiclesSabha Asghar, Susan Monkley, David J F Smith, et al.
Access Microbiology|June 24, 2026
Investigating the lasting effects of SARS-CoV-2 infection and the lung microbiome: no persistent microbial alterations in recovered COVID-19 patients with persistent radiological or respiratory abnormalitiesNancy M Y Teng, Bavithra Vijayakumar, David J F Smith, et al.
The Lancet. Respiratory Medicine|May 22, 2023
Respiratory sequelae of COVID-19: pulmonary and extrapulmonary origins, and approaches to clinical care and rehabilitationSally J Singh, Molly M Baldwin, Enya Daynes, et al.
Annals of the American Thoracic Society|May 9, 2023
The Burden and Impact of Cough in Patients with Idiopathic Pulmonary Fibrosis: An Analysis of the Prospective Observational PROFILE StudyPeter Saunders, Zhe Wu, William A Fahy, et al.
Pageof 2